Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests faster hepatitis c detection for drug users

NCT ID NCT04014179

Knowledge-focused Sponsor: Kirby Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at two faster ways to test for hepatitis C in people who recently injected drugs and visit needle exchange programs. One method uses a fingerstick test with results in about an hour, and the other uses a dried blood spot sent to a lab. The goal was to see if these methods help more people start treatment compared to the usual testing process. Over 1,800 people took part across multiple sites in Australia.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that simpler, faster HCV testing helps more people start treatment, pointing toward better public health strategies.
What could go wrong
This is a completed study comparing testing methods, not a new treatment. Results may not apply to other settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,801 people

The number who actually took part.

Started

Jul 2022

Finished

Apr 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for participants: Attendees of the NSP service are eligible for inclusion if the following criteria are met: 1. Provided written informed consent 2. ≥ 18 years of age 3. Recent injecting drug use - defined as self-reported use within the previous six months. Exclusion criteria for participants: a. Is unable or unwilling to provide informed consent or abide by the requirements of the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic hepatitis C are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic hepatitis C virus infection hepatitis C virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hepatitis C Hepatitis C, chronic

Contacts and locations

Locations

  • Alcohol and Drug Harm Reduction Biala

    Brisbane, Queensland, 4000, Australia

  • Bankstown NSP

    Bankstown, New South Wales, 2200, Australia

  • Coffs Harbour Primary NSP

    Coffs Harbour, New South Wales, 2450, Australia

  • Gosford NSP

    Gosford, New South Wales, 2250, Australia

  • Grafton Primary NSP

    Grafton, New South Wales, 2460, Australia

  • Inala

    Inala, Queensland, 4077, Australia

  • Kempsey Primary NSP

    Kempsey, New South Wales, 2440, Australia

  • Kobi House

    Toowoomba, Queensland, 4350, Australia

  • Liverpool Southwest NSP

    Liverpool, New South Wales, 2170, Australia

  • Noarlunga Health Precinct

    Old Noarlunga, South Australia, 5168, Australia

  • Northern DASSA

    Elizabeth, South Australia, 5112, Australia

  • Orana Centre

    Wollongong, New South Wales, 2500, Australia

  • Severin St NSP (Youth Link)

    Cairns, Queensland, 4870, Australia

  • UC Adelaide

    Adelaide, South Australia, 5000, Australia

  • WSLHD Drug Health - Blacktown NSP

    Blacktown, New South Wales, 2148, Australia

  • WSLHD Drug Health - Mt Druitt NSP

    Mount Druitt, New South Wales, 2770, Australia

  • Wonggangga Turtpandi Aboriginal Primary Health Care Services

    Adelaide, South Australia, 5015, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.